Investments
87Portfolio Exits
10Service Providers
1Latest Northpond Ventures News
Jun 15, 2022
June 15, 2022 09:00 AM Eastern Daylight Time CAMBRIDGE, Mass.--( BUSINESS WIRE )--MIT School of Engineering and Northpond Ventures today announced the launch of the MIT-Northpond Program – Advancing Life Science & Engineering Innovation. The five-year engagement is funded through Northpond Labs, the research and development-focused affiliate of Northpond Ventures . The program aims to generate ideas in the life sciences by connecting Northpond’s experienced venture capital investors with MIT’s scientific entrepreneurs, advancing commercialization through close mentorship and collaboration. Centered within the Department of Biological Engineering, the program will identify MIT researchers engaging in proof-of-concept research projects in the areas of diagnostics, R&D solutions, platforms for therapeutic solutions, biomanufacturing, and AI and software for treatment selection, all with the goal of commercializing their ideas. “This unique program was established with the intent to couple incredible advancements in engineering and biology with innovative entrepreneurial and business opportunities. There is tremendous potential for the MIT-Northpond Program to impact human health by accelerating and commercializing visionary breakthroughs in engineering and life science,” said Anantha P. Chandrakasan, dean of the MIT School of Engineering and Vannevar Bush Professor of Electrical Engineering and Computer Science. The MIT-Northpond Program will support postdoctoral fellows working at the intersection of engineering and life science and provide mentorship for faculty and students. The program will also provide funding to the School of Engineering for its work in the life sciences. “We are honored to be a part of this incredible collaboration and to have the opportunity to provide our faculty, postdoctoral fellows, and students working at the intersection of engineering and biology, with the chance to drive fundamental change and impact,” said Angela Belcher, head of the Department of Biological Engineering, the James Mason Crafts Professor of Biological Engineering and Materials Science, and member of the Koch Institute for Integrative Cancer Research. The MIT-Northpond Program will include the following: Funding up to five translational research projects per year, moving from proof-of-concept to commercialization. Supporting two postdoctoral fellows in the Department of Biological Engineering each year through the School of Engineering’s Postdoctoral Fellowship Program for Excellence, with an emphasis on underrepresented groups, including women. Two faculty mentors will also receive support. Providing discretionary support to the School of Engineering for critical work and advancements in the life sciences. “We have a shared mission and vision to promote and advance science and engineering and to make a marked impact on humanity. We see ourselves as a part of an ecosystem with the potential to advance engineering, science, innovation, and entrepreneurship,” said Michael Rubin, founder and CEO of Northpond Ventures, who will also serve as a visiting scholar in the Department of Biological Engineering. Ernest Fraenkel will serve as faculty lead for the MIT-Northpond Program. Fraenkel is a professor in the Department of Biological Engineering and a member of the Computer Science and Artificial Intelligence Laboratory and the Broad Institute. The program will also include a joint steering committee, comprised of members from both MIT and Northpond where Belcher and Rubin will serve as co-chairs. “Through this program, we can provide transformational entrepreneurial and business opportunities to MIT’s incredible engineering and science talent,” said Sharon Kedar, co-founder and partner of Northpond Ventures. “Together, we will be able to impact humanity.” About Northpond Ventures Northpond Ventures is a multi-billion-dollar science-driven venture capital firm based in Cambridge, MA; San Francisco, CA; and Bethesda, MD. Northpond has been named one of the three most active lead biotech investors in 2021 by Crunchbase, and the most active lead investor in life science solutions and molecular diagnostics by Silicon Valley Bank. It is particularly engaged in the research ecosystem, having led over 50 financings over the past several years, a high percentage of which have an academic origin. Learn more at npv.vc . About MIT School of Engineering The MIT School of Engineering’s mission is to educate the next generation of engineering leaders, to create new knowledge, and to serve society. Learn more at engineering.mit.edu . Contacts
Northpond Ventures Investments
87 Investments
Northpond Ventures has made 87 investments. Their latest investment was in Molecule as part of their Seed VC on June 6, 2022.
Northpond Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
6/13/2022 | Seed VC | Molecule | $13M | Yes | 1 | |
6/7/2022 | Series A | Code Biotherapeutics | $75M | Yes | 7 | |
5/5/2022 | Series C | Vizgen | $85.2M | No | ARCH Venture Partners, Blue Water Life Science Advisors, David Walt, Novalis LifeSciences, Sofina, Tao Capital Partners, and Undisclosed Investors | 3 |
4/28/2022 | Series B | |||||
4/11/2022 | Series A |
Date | 6/13/2022 | 6/7/2022 | 5/5/2022 | 4/28/2022 | 4/11/2022 |
---|---|---|---|---|---|
Round | Seed VC | Series A | Series C | Series B | Series A |
Company | Molecule | Code Biotherapeutics | Vizgen | ||
Amount | $13M | $75M | $85.2M | ||
New? | Yes | Yes | No | ||
Co-Investors | ARCH Venture Partners, Blue Water Life Science Advisors, David Walt, Novalis LifeSciences, Sofina, Tao Capital Partners, and Undisclosed Investors | ||||
Sources | 1 | 7 | 3 |
Northpond Ventures Portfolio Exits
10 Portfolio Exits
Northpond Ventures has 10 portfolio exits. Their latest portfolio exit was Nanoview Biosciences on May 04, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
5/4/2022 | Acquired | 1 | |||
1/7/2022 | IPO | Public | 7 | ||
12/23/2021 | Acquired | 12 | |||
Date | 5/4/2022 | 1/7/2022 | 12/23/2021 | ||
---|---|---|---|---|---|
Exit | Acquired | IPO | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 1 | 7 | 12 |
Northpond Ventures Acquisitions
1 Acquisition
Northpond Ventures acquired 1 company. Their latest acquisition was Saama Technologies on October 20, 2021.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
10/20/2021 | Debt | $79.25M | Acq - Fin | 14 |
Date | 10/20/2021 |
---|---|
Investment Stage | Debt |
Companies | |
Valuation | |
Total Funding | $79.25M |
Note | Acq - Fin |
Sources | 14 |
Northpond Ventures Service Providers
1 Service Provider
Northpond Ventures has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
---|---|---|---|
Counsel | General Counsel |
Service Provider | |
---|---|
Associated Rounds | |
Provider Type | Counsel |
Service Type | General Counsel |
Partnership data by VentureSource
Northpond Ventures Team
4 Team Members
Northpond Ventures has 4 team members, including current Founder, Chief Executive Officer, Michael P. Rubin.
Name | Work History | Title | Status |
---|---|---|---|
ShaRon Kedar | Sands Capital, and McKinsey & Company | Founder | Current |
Micheal Rubin | Founder | Current | |
Michael P. Rubin | Sands Capital, and Sands Capital Ventures | Founder, Chief Executive Officer | Current |
Patrick Smerkers | Chief Financial Officer | Current |
Name | ShaRon Kedar | Micheal Rubin | Michael P. Rubin | Patrick Smerkers |
---|---|---|---|---|
Work History | Sands Capital, and McKinsey & Company | Sands Capital, and Sands Capital Ventures | ||
Title | Founder | Founder | Founder, Chief Executive Officer | Chief Financial Officer |
Status | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.